BlackRock Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $282M | Buy |
2,305,045
+61,368
| +3% | +$7.51M | 0.33% | 53 |
|
|
2016
Q3 | $275M | Buy |
2,243,677
+1,433,769
| +177% | +$176M | 0.34% | 54 |
|
|
2016
Q2 | $94.6M | Buy |
809,908
+139,409
| +21% | +$16.3M | 0.12% | 175 |
|
|
2016
Q1 | $93.3M | Sell |
670,499
-39,314
| -6% | -$5.47M | 0.12% | 172 |
|
|
2015
Q4 | $135M | Sell |
709,813
-6,303
| -0.9% | -$1.2M | 0.17% | 119 |
|
|
2015
Q3 | $112M | Buy |
716,116
+23,907
| +3% | +$3.74M | 0.15% | 138 |
|
|
2015
Q2 | $125M | Buy |
692,209
+222,142
| +47% | +$40.2M | 0.16% | 133 |
|
|
2015
Q1 | $81.5M | Buy |
470,067
+5,668
| +1% | +$982K | 0.11% | 195 |
|
|
2014
Q4 | $85.9M | Sell |
464,399
-515
| -0.1% | -$95.3K | 0.11% | 183 |
|
|
2014
Q3 | $77.1M | Sell |
464,914
-2,901
| -0.6% | -$481K | 0.11% | 184 |
|
|
2014
Q2 | $73.1M | Buy |
467,815
+92,500
| +25% | +$14.5M | 0.1% | 207 |
|
|
2014
Q1 | $57.1M | Buy |
375,315
+33,319
| +10% | +$5.07M | 0.08% | 231 |
|
|
2013
Q4 | $45.4M | Sell |
341,996
-12,624
| -4% | -$1.68M | 0.07% | 265 |
|
|
2013
Q3 | $41.2M | Sell |
354,620
-133,217
| -27% | -$15.5M | 0.07% | 265 |
|
|
2013
Q2 | $45M | Buy |
+487,837
| New | +$45M | 0.08% | 224 |
|